Global Opioids Market Size study & Forecast, by Product Type (Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Others), by Application (Pain Management, Cough Treatment, Diarrhea Treatment) and Regional Analysis, 2022-2029

Global Opioids Market Size study & Forecast, by Product Type (Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Others), by Application (Pain Management, Cough Treatment, Diarrhea Treatment) and Regional Analysis, 2022-2029

Global Opioids Market is valued at approximately USD 22.66 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 1.2% over the forecast period 2022-2029. Opioids are medical agents that act on opioid receptors to cause morphine effects, which are used for pain relief, including anaesthesia. The market growth is driven by the factors such as increasing incidences of chronic pain among the population, a rise in consumption of these drugs to combat pain, coupled with the escalating geriatric population.

The rising number of product approval and the introduction of novel opioid medicines to cure patients suffering from chronic pain are acting as catalyzing factors for the growth of the market. For instance, in August 2020, Olinvyk (oliceridine) injection developed by Trevena, Inc., received Food and Drug Administration (FDA) approval. This new injection is developed to treat adults with acute pain that costs around USD 194 for a supply of 10 ml. Thereby, the rising launch of opioids-associated therapeutics with regulatory approvals is exhibiting a positive influence on market growth across the world. Moreover, growing investments in R&D activities, as well as the increasing healthcare expenditure are presenting various lucrative opportunities over the forecasting years. However, the execution of stringent government regulations for opioid prescription and the rise in opioid addiction (opioid crisis) is restricting the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Opioids Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising increasing approval of opioid-based medicines, along with the unmet medical needs. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing number of initiatives undertaken by the government, as well as rising focus on providing high-quality opioids intended for pain management in the market space.

Major market players included in this report are:
Teva Pharmaceutical Industries Limited
Purdue Pharma LP
AstraZeneca Plc
C.H. Boehringer Sohn Ag and Co. Kg
Johnson & Johnson, Inc.
Sanofi S.A.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Pfizer, Inc.
Sun Pharmaceuticals Industries Limited

Recent Developments in the Market:
 In August 2022, Adalvo announced the acquisition of Onsolis a branded opioid product from a reputed U.S.-based specialty pharmacy company. The product is specially designed to indicate the management of chronic pain in cancer. The objective of this acquisition is to expand the company’s opioid product portfolio and present a high-growth opportunity for the company.

Global Opioids Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Methadone
Codeine
Fentanyl
Oxycodone
Morphine
Hydrocodone
Others
By Application:
Pain Management
Cough Treatment
Diarrhea Treatment

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World



Companies Mentioned

Teva Pharmaceutical Industries Limited
Purdue Pharma LP
AstraZeneca Plc
C.H. Boehringer Sohn Ag and Co. Kg
Johnson & Johnson, Inc.
Sanofi S.A.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Pfizer, Inc.
Sun Pharmaceuticals Industries Limited

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions